Mastek Limited
12,099words
119turns
11analyst exchanges
3executives
Management on call
Hiral Chandrana
GLOBAL CHIEF EXECUTIVE OFFICER, MASTEK GROUP
Arun Agarwal
GLOBAL CHIEF FINANCIAL OFFICER, MASTEK
Damini Jhunjhunwala
ASSISTANT VICE PRESIDENT, INVESTOR RELATIONS, MASTEK
Key numbers — 40 extracted
13.4%
7%
8%
30%
19.2%
25 billion
50 billion
rs,
65%
13.4 %
Rs.570 crore
20.7%
Advertisement
Guidance — 20 items
Hiral Chandrana
opening
“As we look at the next three to four quarters, we have some recovery to do, but with the measures that we've put in place with the investments that we have in Americas, with the continued focus on UK public sector, we believe that we can start looking at beating the industry growth quarter- on-quarter going forward.”
Arun Agarwal
opening
“Again, we expect in a quarter or two for it to streamline and we get back the same run rate with the same customer.”
Mohit Jain
qa
“So, what is happening here and what has changed in last one year in terms of either deal pipeline or deals won and how do we see it going forward in terms of organic growth?”
Hiral Chandrana
qa
“As we've communicated in the past, the approach that we had before in US was really a project-based approach and an implementation- based approach.”
Hiral Chandrana
qa
“This is important because our stickiness of the account goes beyond just the project of implementation.”
Hiral Chandrana
qa
“Of course, with the addition of MST, we expect that to take it to another level because it opens up another avenue for us, because salesforce is almost present in every existing account of ours in the Americas.”
Mohit Jain
qa
“It was more like when should we expect organic growth to pick up, is it like are you guys likely to take two, three quarters, one quarter depending on your deal pipeline, how do you see it moving?”
Hiral Chandrana
qa
“Based on this, I would say in the H2 timeframe which is really Q3 and Q4 timeframe we expect a decent jump both on order book as well as revenue growth, Mohit.”
Mohit Jain
qa
“So, like are we done with it or should we expect something in 2Q and then you expect it to move up?”
Arun Agarwal
qa
“We expect 24% to 25% for FY'23 is a good range as we go on a normalized basis.”
Risks & concerns — 6 flagged
So, was the management bandwidth involved in the acquisition process which led to some decline or declining in the revenues from the US side or the general macro which has impacted the growth over there?
— Nilesh Jethani
I understand it is difficult, but if that could be quantified.
— Mihir Manohar
So, with this spending coming down at an aggregate level, don't you see that the organic growth that we earlier thought of is at risk?
— Amit Chandra
So, it would be difficult really to quantify, but in the space of public sector as we answered in the previous question, most of the projects which we do for public sector are in the space of immigration, borders, customs which are very critical because as different countries are restricting their borders or making it much more pruned to avoid different kind of issues and with Brexit coming together those clearance becomes much much more critical and important.
— Arun Agarwal
So, it's a combination and sometimes informing on the real-time basis become difficult because some of the decision- making is always a part of more discussion to make things happen in a positive way from both sides.
— Arun Agarwal
The impact of the wage revision would be higher than the last year?
— Ashish Das
Advertisement
Q&A — 11 exchanges
Speaking time
35
23
13
6
6
5
5
5
5
4
Advertisement
Opening remarks
Damini Jhunjhunwala
Thank you, Neerav. Good day to all of you. Welcome to the Q1FY23 Earnings Call of Mastek. The Results and the Presentation have already been mailed to you and you can also view it on our website, www.mastek.com. To take us through the results today and answer your questions, we have the top management of Mastek, represented by Mr. Hiral Chandrana - Global CEO and Mr. Arun Agarwal - Global CFO. Hiral will start the call with the business update, followed by Arun providing the financial update for the quarter. As usual, I would like to remind you that anything that is said on this call that reflects any outlook for the future or which may be construed as a forward-looking statement must be viewed in conjunction with the risks and uncertainties that we face. These risks and uncertainties are included, but not limited to what we mentioned in the prospectus filed with SEBI and subsequent annual report that you can find on our website. Having said that, I now hand over the call to Mr. Hiral
Hiral Chandrana
Good afternoon, everyone. Thanks for joining us. I will take a few minutes and provide a “Business Update” and hand it over to Arun to give more details on the “Financials.” We delivered 13.4% year-on-year growth on revenue on a constant currency basis and it was flat on a quarter-on-quarter basis. It was a challenging quarter in some ways where we had a pause in a very large program healthcare account in the UK. There were a few delays in some decisions on some key deals and slower than expected ramp-ups in a couple of accounts. The currency impact was almost 7% to 8% for us from a GBP to US dollar. But having said that, we've got some really good leading indicators that demonstrate the confidence that we have in the business. As you would have seen our backlog has continued to improve. We grew that almost over 30% year-on-year. Our pipeline has been growing steadily even through this last quarter. We have multiple large deals that continue to be added to the pipeline. We've hired mor
Arun Agarwal
Thanks, Hiral. A very warm welcome to everyone on this call. I am going to share with you the key highlights of our performance for the quarter ended 30th June 2022. The investor deck has been circulated ahead of this call and contains much granular details about our financial and operating performance. So, I'm going to keep it quite crisp so that we can spend more time in terms of Q&A. To highlight, this quarter was a mixed bag as highlighted by Hiral. While we have successfully concluded acquisition of MST Solutions and signed the definitive agreement subject to certain closing requirements which team is working to close as early as possible, our quarter was a little bit muted than what we expected. As Hiral earlier mentioned, it was more driven by one of our clients in UK healthcare which has gone through certain reorganization between multiple departments which led to some pause in ramp which we anticipated. Again, we expect in a quarter or two for it to streamline and we get back
Advertisement